References
- LiegerO, ZixJ, Stauffer-BrauchEJ, IizukaT. Synovial chondromatosis of the temporomandibular joint with cranial extension: a case report and literature review. J Oral Maxillofac Surg. 2007;65(10):2073–80.
- AxhausenG. Pathologic und therapie des kiefergelenks [Pathology and therapy for temporomandibular joint]. Fortschr Zahnheilk. 1933;9:171.
- Guarda-NardiniL, PiccottiF, FerronatoG, ManfrediniD. Synovial chondromatosis of temporomandibular joint: a case description with systematic literature review. Int J Oral Maxillofac Surg. 2010;39(8):745–55.
- MilgramJW. The classification of loose bodies in human joint. Clin Orthop. 1977;124:282–91.
- CandelaM, YasuharaR, IwamotoM, Enomoto-IwamotoM. Resident mesenchymal progenitors of articular cartilage. Matrix Biol. 2014;39:44–9.
- DominiciM, Le BlancK, MuellerI, Slaper-CortenbachI, MariniF, KrauseD, et al.Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy. 2006;8(4):315–7.
- OzbeyO, SahinZ, AcarN, OzcelikFT, OzenciAM, KoksoyS, et al. Characterization of colony-forming cells in adult human articular cartilage. Acta Histochemica. 2014;116(5):763–70.
- FinnsonKW, ParkerWL, ChiY, HoemannCD, GoldringMB, AntoniouJ, et al. Endoglin differentially regulates TGF-β-induced Smad2/3 and Smad1/5 signalling and its expression correlates with extracellular matrix production and cellular differentiation state in human chondrocytes. Osteoarthritis Cartilage. 2010;18(11):1518–27.
- GiovanniniS, Diaz-RomeroJ, AignerT, Mainil-VarletP, NesicD. Population doublings and percentage of S100-positive cells as predictors of in vitro chondrogenicity of expanded human articular chondrocytes. J Cell Physiol. 2010;222(2):411–20.
- ChanmeeT, PhothacharoenP, ThongboonkerdV, KasinrerkW, KongtawelertP. Characterization of monoclonal antibodies against a human chondrocyte surface antigen. Monoclonal Antib Immunodiagn Immunother. 2013;32(3):180–6.
- MoriY, KakudoK, GotohM, KuboH, AkiyamaH, YotsuiY. A case of synovial chondromatosis of the temporomandibular joint followed for 17 years. Oral Surg Oral Med Oral Pathol Pral Radiol Endod. 2011;112(1):e35–9.
- YoshitakeH, SatohF, KinoK. Synovial chondromatosis of the temporomandibular joint extending to the middle cranial fossa: A case report. J Jpn Soc Temporomandibular Joint. 2012;24(1):17–21.
- PauM, BicsákA, ReinbacherKE, FeichtingerM, KärcherH. Surgical treatment of synovial chondromatosis of the temporomandibular joint with erosion of the skull base: a case report and review of the literature. Int J Oral Maxillofac Surg. 2014;43(5):600–5.
- TestaverdeL, PerroneA, CaporaliL, ErminiA, IzzoL, D'AngeliI, et al. CT and MR findings in synovial chondromatosis of the temporomandibular joint: our experience and review of literature. Euro J Radiol. 2011;78(3):414–8.
- ChenM, YangC, QiuY, JiangQ, ShiH, WeiW. Synovial chondromatosis of the temporomandibular joint: relationship between MRI information and potential aggressive behavior. J Craniomaxillofac Surg. 2015;43(3):349–54.
- FujitaS, IizukaT, YoshidaH, SegamiN. Transforming growth factor and tenascin in synovial chondromatosis of the temporomandibular joint: Report of a case. Int J Oral Maxillofac Surg. 1997;26(4):258–9.
- LiY, MozenL, CaiH, FangW, MengQ, LiJ, et al. Transforming growth factor beta 3 involved in the pathogenesis of the synovial chondromatosis of temporomandibular joint. Sci Rep. 2015;5:8843.
- SatoJ, SegamiN, SuzukiT, YoshitakeY, NishikawaK. The expression of fibroblast growth factor-2 and fibroblast growth factor receptor-1 in chondrocytes in synovial chondromatosis of the temporomandibular joint. Report of two cases. Int J Oral Max Surg. 2002;31(5):532–6.
- SatoJ, SegamiN, YoshitakeY, NashikawaK. Correlations of the expression of fibroblast growth factor-2, vascular endothelial growth factor, and their receptors with angiogenesis in synovial tissues from patients with internal derangement of the temporomandibular joint. J Dent Res. 2003;82(4):272–7.
- TojyoI, YamagutiA, OzakiH, FujitaS. The expression of fibroblast growth factor receptor-3 in synovial chondromatosis of the temporomandibular joint. Arch Oral Biol. 2004;49(7):591–4.
- NakanishiS, SakamotoK, YoshitakeH, KinoK, AmagasaT, YamaguchiA. Bone morphogenetic proteins are involved in the pathobiology of synovial chondromatosis. Biochem Biophys Res Commun. 2009;379(4):914–9.
- YoshidaH, TsujiK, OshiroN, WatoM, MoritaS. Preliminary report of Ki-67 reactivity in synovial chondromatosis of the temporomandibular joint: An immunohistochemical study. J Craniomaxillofac Surg. 2013;41(6):473–5.
- SomozaRA, WelterJF, CorreaD, CaplanAI. Chondrogenic differentiation of mesenchymal stem cells: challenges and unfulfilled expectations. Tissue Eng Part B Rev. 2014;20(6):596–608.
- BakerT, HagoodJ. Getting grip on Thy-1 signaling. Biochim Biophys Acta. 2009;1793(5):921–3.
- ParkerW, GoldringM, PhilipA. Endoglin is expressed on human chondrocytes and forms a heteromeric complex with betaglycan in a ligand and type II TGFβ receptor independent manner. J Bone Miner Res. 2003;13(2):289–302.
- FujitaS, YoshidaH, TojyoI, WadaT, MurakamiK, IizukaT. Synovial chondromatosis of the temporomandibular joint: clinical and immunohistological considerations. Br J Oral Maxillofac Surg. 2004;42(3):259–60.
- DavisRI, FosterH, ArthurK, TrewinS, HamiltonPW, BiggartDJ. Cell proliferation studies in primary synovial chondromatosis. J Pathol. 1998;184(1):18–23.
- LeytonL, HagoodJS. Thy-1 modulates neurological cell-cell and cell-matrix interactions through multiple molecular interactions. Adv Neurobiol. 2014;8:3–20.
- GroganS, BarberoA, Diaz-RomeroJ, Cleton-JansenA, SoederS, WhitsideR, et al.Identification of markers to characterize and sort human articular chondrocytes with enhanced in vitro chondrogenic capacity. Arthritis Rheum. 2007;56(2):586–95.